{"record":{"code":"W-01648","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN","buyer":"","amount":135200,"currency":null,"records":1,"found":"2026-10-04","refs":["SICM-428-2022","ocds-5wno2w-CE-20260003105159-54651","2012-08-07"],"id":"W-01648","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01648/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01648/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN», 135,200 USD (≈ $135,200); method direct (Catálogo electrónico - Compra directa en el convenio SICM-428-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20260003105159-54651; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","135,200",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01648",null],["Reference","SICM-428-2022",null],["Reference","ocds-5wno2w-CE-20260003105159-54651",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER CIA. LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «HOSPITAL DE ESPECIALIDADES CARLOS ANDRADE MARIN», 135,200 USD (≈ $135,200); method direct (Catálogo electrónico - Compra directa en el convenio SICM-428-2022, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTOS EN EL CATÁLOG; OCID ocds-5wno2w-CE-20260003105159-54651; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"aa672a95"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Ecuador","iso2":"EC","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":84,"new_today":0,"on_pages":84,"full_list":[],"html":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01648/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01648/index.json"}